Quantcast
Last updated on April 18, 2014 at 11:27 EDT

Latest Patient-controlled analgesia Stories

2013-12-16 08:25:46

- FDA establishes the PDUFA action date of July 27, 2014 for Zalviso - REDWOOD CITY, Calif. and AACHEN, Germany, Dec. 16, 2013 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX) and Grunenthal GmbH announced today that they have entered into a commercial collaboration, covering the territory of the European Union, certain other European countries and Australia for ZALVISO(TM) (previously known as ARX-01) for potential use in pain treatment within or dispensed by a hospital,...

2013-12-02 08:30:47

REDWOOD CITY, Calif., Dec. 2, 2013 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that the Zalviso(TM) New Drug Application (NDA) was accepted for filing by the FDA on November 26, 2013. The acceptance for filing of the NDA indicates the FDA has determined that the application is sufficiently complete to...

2013-10-31 08:34:37

CHICAGO, Oct. 31, 2013 /PRNewswire/ -- The Physician-Patient Alliance for Health & Safety today released an infograph on the first national survey of United States hospitals on the administration of patient-controlled analgesia (PCA). (Logo: http://photos.prnewswire.com/prnh/20131024/CG03341LOGO) The infograph can be viewed and downloaded at http://ppahs.org/2013/10/30/infographic-first-national-survey-of-patient-controlled-analgesia-practices/ According to reports made to...

2013-10-29 23:21:32

Reportbuyer.com just published a new market research report: European Markets for Infusion Therapy Devices. London (PRWEB) October 29, 2013 The electronic ambulatory/patient controlled analgesia (PCA) and syringe infusion pump segments are expected to see moderate to high single-digit growth rates until at least 2019. In 2012, the total European market for infusion therapy devices was valued at over €505 million. This market comprises a mixture of capital equipment and one-time use...

2013-10-24 08:36:22

Inconsistency in safe practices most likely accounts for large proportion of adverse events and deaths associated with PCA use, says Physician-Patient Alliance for Health and Safety CHICAGO, Oct. 24, 2013 /PRNewswire/ -- The Physician-Patient Alliance for Health and Safety today released the results from a national survey of United States hospitals on the administration of patient-controlled analgesia (PCA). (Logo: http://photos.prnewswire.com/prnh/20131024/CG03341LOGO) According...

2013-10-17 08:30:45

Respiratory Monitoring Helps to Protect Patients on Pain Medication ROCK HILL, S.C., Oct. 17, 2013 /PRNewswire/ -- Piedmont Medical Center recently strengthened patient safety measures by expanding its use of capnography to monitor patients using patient-controlled analgesia (PCA) to regulate their pain after surgery. PCA can provide an effective way to control pain by allowing patients to self-administer small doses of pain medication intravenously, but the technology poses unique...

2013-10-16 08:29:06

CHICAGO, Oct. 16, 2013 /PRNewswire/ -- The Physician-Patient Alliance for Health & Safety (PPAHS) today announced the release of major patient safety findings of the first national survey of patient-controlled analgesia (PCA) practices presented at the recent Society of Anesthesia and Sleep Medicine (SASM) 3rd Annual Conference held October 10-11, 2013. According to reports made to the Food and Drug Administration between 2005 and 2009, more than 56,000 adverse events and 700...

2013-09-30 23:25:36

Reportbuyer.com just published a new market research report: Infusion Pumps: Technology and Market 2013-2023. London (PRWEB) September 30, 2013 Report Details Your guide to trends and revenue prospects for infusion pumps What does the future hold for the infusion pumps market? Visiongain's new report gives you forecasted revenues to 2023. It explains trends, opportunities and prospects for infusion pumps. There's rising demand for those products. Our study lets you assess sales...

2013-09-30 08:28:57

Zalviso NDA submitted for the management of moderate-to-severe acute pain in adult patients in the hospital setting REDWOOD CITY, Calif., Sept. 30, 2013 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that it submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Zalviso(TM)...

2013-08-21 12:27:02

Respiratory Monitoring Helps to Protect Patients on Pain Medication ATHENS, Ga., Aug. 21, 2013 /PRNewswire/ -- Athens Regional Medical Center recently strengthened patient safety measures by expanding its use of capnography to monitor patients using patient-controlled analgesia (PCA) to regulate their pain after surgery. PCA can provide an effective way to control pain by allowing patients to self-administer small doses of pain medication intravenously, but the technology poses...